The effect of glucocorticoids on tendon cell viability in human tendon explants

Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of n...

Full description

Saved in:
Bibliographic Details
Published inActa orthopaedica Vol. 80; no. 3; pp. 363 - 367
Main Authors Wan Nar Wong, Margaret, Lui, Wai Ting, Chuen Fu, Sai, Man Lee, Kwong
Format Journal Article
LanguageEnglish
Published Basingstoke Informa UK Ltd 2009
Taylor & Francis
Informa Healthcare
Subjects
Online AccessGet full text
ISSN1745-3674
1745-3682
DOI10.3109/17453670902988386

Cover

Loading…
Abstract Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability. Methods Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco’s modification of Eagle’s Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 μM (control), 10 μM, or 100 μM dexamethasone sodium phosphate or 0 μM (control), 10 μM, or 100 μM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment. Results Incubation with 10 μM and 100 μM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 μM and 100 μM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA). Interpretation Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties.
AbstractList Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability. Methods Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco’s modification of Eagle’s Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 μM (control), 10 μM, or 100 μM dexamethasone sodium phosphate or 0 μM (control), 10 μM, or 100 μM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment. Results Incubation with 10 μM and 100 μM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 μM and 100 μM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA). Interpretation Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties.
Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability.BACKGROUND AND PURPOSEPrevious studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability.Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 microM (control), 10 microM, or 100 microM dexamethasone sodium phosphate or 0 microM (control), 10 microM, or 100 microM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment.METHODSPrimary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 microM (control), 10 microM, or 100 microM dexamethasone sodium phosphate or 0 microM (control), 10 microM, or 100 microM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment.Incubation with 10 microM and 100 microM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 microM and 100 microM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA).RESULTSIncubation with 10 microM and 100 microM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 microM and 100 microM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA).Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties.INTERPRETATIONHuman tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties.
Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability. Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 microM (control), 10 microM, or 100 microM dexamethasone sodium phosphate or 0 microM (control), 10 microM, or 100 microM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment. Incubation with 10 microM and 100 microM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 microM and 100 microM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA). Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties.
Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell proliferation, and reduce collagen synthesis. However, such cell cultures lack the extracellular matrix and three-dimensional structure of normal tendons, which affects their response to stimuli. We established a human tendon explant culture system and tested the effects of dexamethasone and triamcinolone on cell viability. Methods Primary human tendon explant cultures were prepared from healthy hamstring tendons. Tendon strips were harvested from hamstring tendons and cultured in 24-well plates in Dulbecco's modification of Eagle's Medium (DMEM) supplemented with 2% fetal calf serum. The tendon explants were treated with 0 μM (control), 10 μM, or 100 μM dexamethasone sodium phosphate or 0 μM (control), 10 μM, or 100 μM triamcinolone acetonide in DMEM for 96 h. Cell viability was measured by Alamar blue assay before and after glucocorticoid treatment. Results Incubation with 10 μM and 100 μM dexamethasone reduced cell viability in human tendon explants by 35% and 45%, respectively, as compared to a 6% increase in the controls (p = 0.01, mixed-effects ANOVA). Triamcinolone at 10 μM and 100 μM reduced cell viability by 33% and 36%, respectively, as compared to a 9% increase in the controls (p = 0.07, mixed-effects ANOVA). Interpretation Human tendon explant cultures can be used to study the effects of glucocorticoids on human tendon. Dexamethasone and triamcinolone suppress the cell viability of human tendon in its natural 3-dimensional environment with matrix anchorage. Human tendon explant cultures provide a species-specific model for further investigation of the effects of glucocorticoids on the metabolism of the extracellular matrix of human tendon, and on its mechanical properties.
Author Lui, Wai Ting
Chuen Fu, Sai
Man Lee, Kwong
Wan Nar Wong, Margaret
Author_xml – sequence: 1
  givenname: Margaret
  surname: Wan Nar Wong
  fullname: Wan Nar Wong, Margaret
  email: mwnwong@cuhk.edu.hk
  organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong
– sequence: 2
  givenname: Wai Ting
  surname: Lui
  fullname: Lui, Wai Ting
  email: mwnwong@cuhk.edu.hk
  organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong
– sequence: 3
  givenname: Sai
  surname: Chuen Fu
  fullname: Chuen Fu, Sai
  email: mwnwong@cuhk.edu.hk
  organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong
– sequence: 4
  givenname: Kwong
  surname: Man Lee
  fullname: Man Lee, Kwong
  email: mwnwong@cuhk.edu.hk
  organization: 1Department of Orthopaedics, Traumatology Shatin, Shatin, Hong Kong
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21669022$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19421908$$D View this record in MEDLINE/PubMed
BookMark eNp9kcuKFDEUhoOMOBd9ADdSG3HVmkulkkIRZPAGA7MZ1-FUKpnKkE7aJDXab2-a7ikchd7khJzvP5f85-gkxGAQeknwW0Zw_46IlrNO4B7TXkomuyfobPe2Yp2kJ8tdtKfoPOc7jJlse_wMnZK-paTH8gxd30ymMdYaXZpom1s_66hjKk5HN-YmhqaYMNagjffNvYPBeVe2jQvNNK9hSZvfGw-h5OfoqQWfzYtDvEA_vny-ufy2urr--v3y09VKc96VFddMCwmG4NZoUw8GVtCBj1JorqUBzkUnOgBrta07MtuPuNUDHqSkuOPsAn3c193Mw9qM2oSSwKtNcmtIWxXBqceZ4CZ1G-8VlZRRQmqBN4cCKf6cTS5q7fJuSQgmzlkJ1laQt20lX_3daunx8IkVeH0AIGvwNkHQLi8cJV1XHaKVE3tOp5hzMlZpV6C4uJvQeUWw2tmq_rO1Ksk_ymWII5oPe40LNqY1_IrJj6rA1sf0MCI7Jn__SD4Z8GXSkIy6i3MK1dwjzf8AzXDKRg
CitedBy_id crossref_primary_10_1302_0301_620X_94B6_29063
crossref_primary_10_1002_jor_22193
crossref_primary_10_3928_01477447_20120327_22
crossref_primary_10_1002_jor_24451
crossref_primary_10_1186_s12891_016_1328_9
crossref_primary_10_2460_ajvr_79_2_199
crossref_primary_10_1177_0363546516664161
crossref_primary_10_1177_03635465221145949
crossref_primary_10_1097_JSM_0000000000000603
crossref_primary_10_1136_annrheumdis_2012_203146
crossref_primary_10_1080_03008207_2018_1501040
crossref_primary_10_1210_en_2010_1087
crossref_primary_10_1302_2046_3758_312_2000321
crossref_primary_10_1016_j_jse_2011_11_009
crossref_primary_10_1080_14740338_2017_1276561
crossref_primary_10_1039_C6RA23620K
crossref_primary_10_1007_s00132_009_1490_y
crossref_primary_10_1016_j_jot_2016_08_002
crossref_primary_10_1155_2020_8832218
crossref_primary_10_1302_2046_3758_81_BJR_2018_0181_R1
crossref_primary_10_1016_j_jsbmb_2015_04_010
crossref_primary_10_2106_JBJS_RVW_19_00052
crossref_primary_10_1259_bjr_20150577
crossref_primary_10_1080_03008207_2019_1700962
crossref_primary_10_1177_039139881203501105
crossref_primary_10_1186_s12891_019_2896_2
crossref_primary_10_1210_jc_2012_1681
crossref_primary_10_3390_ijms20081972
crossref_primary_10_1016_j_biopha_2022_112693
crossref_primary_10_1016_j_pmrj_2016_02_008
crossref_primary_10_3389_fnagi_2016_00186
crossref_primary_10_1016_j_semarthrit_2013_08_006
crossref_primary_10_1186_1476_9255_9_40
crossref_primary_10_1177_1759720X231214903
crossref_primary_10_1016_j_fas_2013_04_009
crossref_primary_10_1038_s41598_020_70994_z
Cites_doi 10.1114/1.1567282
10.1042/bj2460589
10.1016/S1385-299X(97)00045-7
10.1097/01.blo.0000118184.83983.65
10.1016/S0021-9258(18)41617-1
10.1002/jor.1100160512
10.2106/00004623-199511000-00006
10.1002/jor.1100090406
10.2106/00004623-200310000-00008
10.1002/(SICI)1097-4652(199701)170:1<69::AID-JCP8>3.0.CO;2-J
10.1042/bj1950573
10.1016/0167-4781(91)90082-W
10.1677/joe.0.1420571
10.1007/BF00614309
10.1097/00003086-199611000-00032
10.1080/00016470152846646
10.3109/03008208609017470
ContentType Journal Article
Copyright 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009
2009 INIST-CNRS
Copyright: © Nordic Orthopedic Federation 2009
Copyright_xml – notice: 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009
– notice: 2009 INIST-CNRS
– notice: Copyright: © Nordic Orthopedic Federation 2009
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.3109/17453670902988386
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1745-3682
EndPage 367
ExternalDocumentID PMC2823211
19421908
21669022
10_3109_17453670902988386
399010
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
04C
0R~
0YH
23M
2QV
2WC
34G
36B
39C
3O-
4.4
53G
5GY
5RE
5VS
6J9
6PF
AALIY
AAUGY
AAWTL
ABDBF
ABNNA
ABPTK
ACGFO
ACGFS
ADBBV
ADCVX
ADRAZ
ADRBQ
AEGXH
AENEX
AFFNX
AFKVX
AJWEG
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AWYRJ
BAWUL
BCNDV
BMSDO
C1A
CAG
COF
CS3
DIK
DXH
E3Z
EAP
EBC
EBD
EBS
EBX
ECF
ECT
ECV
EHN
EIHBH
EJD
EMB
EMK
EMOBN
ENC
ENX
EPL
EPT
ESX
F5P
FRP
GROUPED_DOAJ
GX1
H13
HYE
J.N
KQ8
M48
M4Z
M~E
O5R
O5S
O9-
OK1
P2P
Q~Q
RDKPK
RNS
RPM
SV3
TFDNU
TFL
TFMNY
TFW
TR2
TUS
W2D
WQ9
X7M
ZXP
~1N
ACUHS
ADOJX
TDBHL
AAFWJ
AAYXX
AFPKN
CITATION
OVT
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c556t-5c3c78ae104ece04e3af72b5d87c5c8ea557676aaffcf5363f9d04cb0b8820653
IEDL.DBID M48
ISSN 1745-3674
IngestDate Thu Aug 21 18:25:41 EDT 2025
Fri Jul 11 03:40:09 EDT 2025
Mon Jul 21 06:03:15 EDT 2025
Mon Jul 21 09:14:33 EDT 2025
Tue Jul 01 04:04:23 EDT 2025
Thu Apr 24 23:13:06 EDT 2025
Wed Dec 25 09:01:53 EST 2024
Wed Jun 21 13:15:12 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Human
Explant
Glucocorticoid
Viability
Orthopedics
Tendon
Language English
License CC BY 4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c556t-5c3c78ae104ece04e3af72b5d87c5c8ea557676aaffcf5363f9d04cb0b8820653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3109/17453670902988386
PMID 19421908
PQID 734232544
PQPubID 23479
PageCount 5
ParticipantIDs pubmed_primary_19421908
informahealthcare_journals_10_3109_17453670902988386
crossref_citationtrail_10_3109_17453670902988386
crossref_primary_10_3109_17453670902988386
pascalfrancis_primary_21669022
proquest_miscellaneous_734232544
informaworld_taylorfrancis_310_3109_17453670902988386
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2823211
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-00-00
PublicationDateYYYYMMDD 2009-01-01
PublicationDate_xml – year: 2009
  text: 2009-00-00
PublicationDecade 2000
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
PublicationTitle Acta orthopaedica
PublicationTitleAlternate Acta Orthop
PublicationYear 2009
Publisher Informa UK Ltd
Taylor & Francis
Informa Healthcare
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
– name: Informa Healthcare
References Yoshikawa Y (CIT0024) 2001; 72
Scott JE (CIT0015) 1986; 14
Tsai WC (CIT0018) 2002; 29
Oikarinen A (CIT0013) 1991; 1089
Abrahamsson SO (CIT0001) 1991; 9
Wiggins ME (CIT0021) 1995; 77
Clark RA (CIT0007) 1997; 170
Nakano T (CIT0012) 1993; 268
Elliott DM (CIT0008) 2003; 31
Yuksel H (CIT0025) 2001; 11
Koob TJ (CIT0010) 1987; 246
CIT0016
Fu SC (CIT0009) 2005
Chan BP (CIT0006) 1998; 16
Voytik-harbin SL (CIT0020) 1998; 30
Chan BP (CIT0005) 1997
Campbell RB (CIT0004) 1996
Bird JLE (CIT0002) 1994; 142
Loew D (CIT0011) 1986; 30
British NATIONAL (CIT0003) 2003
Springer JE (CIT0017) 1998; 2
Vogel KG (CIT0019) 1992; 59
Wong MWN (CIT0023) 2004
Wong MWN (CIT0022) 2003; 85
Pagé B (CIT0014) 1993; 3
9308546 - Clin Orthop Relat Res. 1997 Sep;(342):239-47
9012786 - J Cell Physiol. 1997 Jan;170(1):69-80
9820284 - J Orthop Res. 1998 Sep;16(5):597-603
9630663 - Brain Res Brain Res Protoc. 1998 Jun;2(4):259-63
3709651 - Eur J Clin Pharmacol. 1986;30(2):225-30
1493795 - Eur J Cell Biol. 1992 Dec;59(2):304-13
6459082 - Biochem J. 1981 Jun 1;195(3):573-81
21573387 - Int J Oncol. 1993 Sep;3(3):473-6
2045977 - J Orthop Res. 1991 Jul;9(4):503-15
3689324 - Biochem J. 1987 Sep 15;246(3):589-98
11480607 - Acta Orthop Scand. 2001 Jun;72(3):287-92
12757203 - Ann Biomed Eng. 2003 May;31(5):599-605
14563798 - J Bone Joint Surg Am. 2003 Oct;85-A(10):1914-20
2938882 - Connect Tissue Res. 1986;14(4):267-78
12415599 - J Rheumatol. 2002 Nov;29(11):2397-402
9557942 - In Vitro Cell Dev Biol Anim. 1998 Mar;34(3):239-46
15123960 - Clin Orthop Relat Res. 2004 Apr;(421):277-81
7593077 - J Bone Joint Surg Am. 1995 Nov;77(11):1682-91
8226804 - J Biol Chem. 1993 Oct 25;268(30):22941-7
15685080 - Clin Orthop Relat Res. 2005 Feb;(431):226-32
11831452 - J Investig Allergol Clin Immunol. 2001;11(3):188-92
8913169 - Clin Orthop Relat Res. 1996 Nov;(332):242-53
2025646 - Biochim Biophys Acta. 1991 May 2;1089(1):40-6
7525827 - J Endocrinol. 1994 Sep;142(3):571-9
References_xml – volume: 31
  start-page: 599
  year: 2003
  ident: CIT0008
  publication-title: Ann Biomed Engineering
  doi: 10.1114/1.1567282
– volume: 246
  start-page: 589
  issue: 3
  year: 1987
  ident: CIT0010
  publication-title: Biochem J
  doi: 10.1042/bj2460589
– volume: 30
  start-page: 354
  year: 1998
  ident: CIT0020
  publication-title: In Vitro Cell Dev Biol-Animal
– volume: 2
  start-page: 259
  year: 1998
  ident: CIT0017
  publication-title: Brain Res Potocols
  doi: 10.1016/S1385-299X(97)00045-7
– start-page: 277
  issue: 421
  year: 2004
  ident: CIT0023
  publication-title: Clin Orthop
  doi: 10.1097/01.blo.0000118184.83983.65
– volume: 268
  start-page: 22941
  year: 1993
  ident: CIT0012
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)41617-1
– volume: 29
  start-page: 2397
  issue: 11
  year: 2002
  ident: CIT0018
  publication-title: J Rheumatology
– volume: 3
  start-page: 473
  year: 1993
  ident: CIT0014
  publication-title: Int J Oncol
– volume: 16
  start-page: 597
  year: 1998
  ident: CIT0006
  publication-title: J Orthop Res
  doi: 10.1002/jor.1100160512
– volume: 77
  start-page: 1682
  year: 1995
  ident: CIT0021
  publication-title: J Bone Joint Surg (Am)
  doi: 10.2106/00004623-199511000-00006
– volume: 9
  start-page: 503
  issue: 4
  year: 1991
  ident: CIT0001
  publication-title: J Orthop Res
  doi: 10.1002/jor.1100090406
– start-page: 226
  issue: 431
  year: 2005
  ident: CIT0009
  publication-title: Clin Orthop
– volume: 85
  start-page: 1914
  year: 2003
  ident: CIT0022
  publication-title: J Bone Joint Surg (Am)
  doi: 10.2106/00004623-200310000-00008
– volume: 59
  start-page: 304
  issue: 2
  year: 1992
  ident: CIT0019
  publication-title: Eur J Cell Biol
– start-page: 239
  issue: 342
  year: 1997
  ident: CIT0005
  publication-title: Clin Orthop
– volume: 170
  start-page: 69
  year: 1997
  ident: CIT0007
  publication-title: J Cell Physiol
  doi: 10.1002/(SICI)1097-4652(199701)170:1<69::AID-JCP8>3.0.CO;2-J
– ident: CIT0016
  doi: 10.1042/bj1950573
– start-page: 345
  year: 2003
  ident: CIT0003
  publication-title: Royal Pharmaceutical Society of Great Britain
– volume: 1089
  start-page: 40
  year: 1991
  ident: CIT0013
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0167-4781(91)90082-W
– volume: 142
  start-page: 571
  year: 1994
  ident: CIT0002
  publication-title: J Endocrinol
  doi: 10.1677/joe.0.1420571
– volume: 30
  start-page: 225
  year: 1986
  ident: CIT0011
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/BF00614309
– volume: 11
  start-page: 188
  year: 2001
  ident: CIT0025
  publication-title: J Investig Allergol Clin Immunol
– start-page: 242
  issue: 332
  year: 1996
  ident: CIT0004
  publication-title: Clin Orthop
  doi: 10.1097/00003086-199611000-00032
– volume: 72
  start-page: 287
  issue: 3
  year: 2001
  ident: CIT0024
  publication-title: Acta Orthop Scand
  doi: 10.1080/00016470152846646
– volume: 14
  start-page: 267
  year: 1986
  ident: CIT0015
  publication-title: Conn Tiss Res
  doi: 10.3109/03008208609017470
– reference: 9820284 - J Orthop Res. 1998 Sep;16(5):597-603
– reference: 2938882 - Connect Tissue Res. 1986;14(4):267-78
– reference: 6459082 - Biochem J. 1981 Jun 1;195(3):573-81
– reference: 8226804 - J Biol Chem. 1993 Oct 25;268(30):22941-7
– reference: 2045977 - J Orthop Res. 1991 Jul;9(4):503-15
– reference: 3689324 - Biochem J. 1987 Sep 15;246(3):589-98
– reference: 12757203 - Ann Biomed Eng. 2003 May;31(5):599-605
– reference: 15123960 - Clin Orthop Relat Res. 2004 Apr;(421):277-81
– reference: 7525827 - J Endocrinol. 1994 Sep;142(3):571-9
– reference: 9308546 - Clin Orthop Relat Res. 1997 Sep;(342):239-47
– reference: 9630663 - Brain Res Brain Res Protoc. 1998 Jun;2(4):259-63
– reference: 12415599 - J Rheumatol. 2002 Nov;29(11):2397-402
– reference: 21573387 - Int J Oncol. 1993 Sep;3(3):473-6
– reference: 7593077 - J Bone Joint Surg Am. 1995 Nov;77(11):1682-91
– reference: 3709651 - Eur J Clin Pharmacol. 1986;30(2):225-30
– reference: 1493795 - Eur J Cell Biol. 1992 Dec;59(2):304-13
– reference: 2025646 - Biochim Biophys Acta. 1991 May 2;1089(1):40-6
– reference: 14563798 - J Bone Joint Surg Am. 2003 Oct;85-A(10):1914-20
– reference: 11831452 - J Investig Allergol Clin Immunol. 2001;11(3):188-92
– reference: 9557942 - In Vitro Cell Dev Biol Anim. 1998 Mar;34(3):239-46
– reference: 9012786 - J Cell Physiol. 1997 Jan;170(1):69-80
– reference: 11480607 - Acta Orthop Scand. 2001 Jun;72(3):287-92
– reference: 8913169 - Clin Orthop Relat Res. 1996 Nov;(332):242-53
– reference: 15685080 - Clin Orthop Relat Res. 2005 Feb;(431):226-32
SSID ssj0038490
Score 2.082941
Snippet Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell...
Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcinolone reduce cell viability, suppress cell proliferation, and...
Background and purpose Previous studies on the culture of human tenocytes have shown that dexamethasone and triamcino-lone reduce cell viability, suppress cell...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
informaworld
informahealthcare
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 363
SubjectTerms Biological and medical sciences
Cell Survival - drug effects
Cells, Cultured
Dexamethasone - pharmacology
Diseases of the osteoarticular system
Glucocorticoids - pharmacology
Humans
Medical sciences
Tendons - cytology
Tendons - drug effects
Tendons - metabolism
Triamcinolone - pharmacology
Title The effect of glucocorticoids on tendon cell viability in human tendon explants
URI https://www.tandfonline.com/doi/abs/10.3109/17453670902988386
https://www.ncbi.nlm.nih.gov/pubmed/19421908
https://www.proquest.com/docview/734232544
https://pubmed.ncbi.nlm.nih.gov/PMC2823211
Volume 80
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT-MwEB7xuOwFgYAlC1Q-cFopS4jtxDkghBAIIcFethK3yHFsUalKoC0r-PfMOA8oFLikkTyTtJ6xPN94-g3AgSmiIhHOhoJHJV4yG6oE7zJtSx4bFVvfM_L6JrkciqtbebsEXXurdgKnC6Ed9ZMaTsZ_nh6eT3DBH3vEGWWHGFRLz0NGdOKKq2QZVnFjSqmTw7XoDxW4Eln7_0gZorxoDjkXP2Jum1pvSUzv-pKsd8SmVFGppziprumGsShcfV91-WYbu1iHtTb-ZKeNw2zAkq024S86C2sqO1jtmC9jR1SKIvWonLK6YpQpxw9K87P_o4bb-5mNKuZ7_HXD9ul-THU1WzC8OP93dhm2nRZCI2UyC6XhJlXaIjazxuKFa5fGhSxVaqRRVkuEJWmitXPG4URxl5WRIDsr4n-XfBtWqrqyO8BQw5UpQu6jQgmUJ_750mCQWGIool0WQNRNbG5aGnLqhjHOEY6QLfIPtgjgd69y33BwfCUsPlgr79zqKzX51qD5zOdLWnOSzqd6gznL918wPkoSlIoDYJ0r5LhyyU66svXjNE-JfJEY4gL42XjG66_LBO4kkQognfOZXoBIwedHqtGdJwdHCM0R1P_6_rW78KM5GqN80h6szCaPdh8jrFkx8JmJgV89L-QPIOU
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+glucocorticoids+on+tendon+cell+viability+in+human+tendon+explants&rft.jtitle=Acta+orthopaedica&rft.au=Wong%2C+Margaret+Wan+Nar&rft.au=Lui%2C+Wai+Ting&rft.au=Fu%2C+Sai+Chuen&rft.au=Lee%2C+Kwong+Man&rft.date=2009&rft.issn=1745-3674&rft.volume=80&rft.issue=3&rft.spage=363&rft_id=info:doi/10.3109%2F17453670902988386&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-3674&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-3674&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-3674&client=summon